- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 3, 2025 | 12.06M sh |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $47.8M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $43.06M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $325.6M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $315.33M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $396.67M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $428.02M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $416.34M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $445.11M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $761.94M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $776.48M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $912.68M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $928.18M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 12.17M sh |
| Dividends Paid | Q1 2025 · Dec 31, 2023 | $3.12M |
| Capex | Q1 2025 · Dec 31, 2023 | $1.24M |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $83.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $366.32M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $345.03M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $1.98 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $2.02 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $20.35M |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $1.97M |
| Net Income | Q1 2025 · Dec 31, 2023 | $24.09M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $25.88M |
| Gross Profit | Q1 2025 · Dec 31, 2023 | $48.19M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $145.82M |
| Revenue | Q1 2025 · Dec 31, 2023 | $194.02M |